Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations for non-diabetes specialists on the use of sodium glucose co-transporter 2 inhibitors in people with type 2 diabetes (January 2021)

Sodium glucose co-transporter 2 (SGLT2) inhibitors are now an established class of medications for the treatment of type 2 diabetes (T2D), no longer reserved for use by specialists in diabetes. They are being used increasingly for their cardiac and renal benefits by primary care, cardiology and rena...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Med (Lond)
Hlavní autoři: Dashora, Umesh, Gregory, Robert, Winocour, Peter, Dhatariya, Ketan, Rowles, Susannah, Macklin, Andrew, Rayman, Gerry, Nagi, Dinesh, Whitehead, Katie, Beba, Hannah, De, Parijat, Patel, Dipesh C
Médium: Artigo
Jazyk:Inglês
Vydáno: Royal College of Physicians 2021
Témata:
Concise Guidance
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8140708/
https://ncbi.nlm.nih.gov/pubmed/34001571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7861/clinmed.2021-0045
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky